acquired
Stage
About
IntegerBio is an immunovirology company that develops broad therapeutics targeting multiple viruses by combining immunology and virology science for durable responses.
Explore IntegerBio, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.